OBJECTIVE: To examine the relationship between day-3 morphology and euploidy for individual chromosomes in embryos that develop to the blastocyst stage by day 5. DESIGN: Retrospective cohort study. SETTING: Boston IVF, a large university-affiliated reproductive medicine practice. PATIENT(S): Ninety-nine patients undergoing their first preimplantation genetic screening (PGS) cycle between January 1 and December 31, 2006. INTERVENTION(S): In vitro fertilization (IVF) and preimplantation genetic screening (PGS). MAIN OUTCOME MEASURE(S): Prevalence of euploidy for chromosomes X, Y, 8, 13, 14, 15, 16, 17, 18, 20, 21, and 22 in day-3 high implantation potential (HIP) versus non-HIP embryos that grew to day-5 blastocysts. RESULT(S): Seven hundred three embryos from 99 cycles in 99 patients underwent PGS. Three hundred sixty-four (52%) embryos from 88 cycles in 88 patients developed to the blastocyst stage by day 5. High implantation potential embryos were more likely to be euploid for chromosomes X/Y, 8, 15, 16, 18, and 22 compared with non-HIP embryos, with similar trends for chromosomes 14 and 17. There were no statistically significant differences between HIP and non-HIP embryos in euploidy prevalence for chromosomes 13, 20, and 21. CONCLUSION(S): Our data suggest that PGS may detect potentially viable but detrimental chromosomal abnormalities that are not detected by embryo morphology alone.
OBJECTIVE: To examine the relationship between day-3 morphology and euploidy for individual chromosomes in embryos that develop to the blastocyst stage by day 5. DESIGN: Retrospective cohort study. SETTING:Boston IVF, a large university-affiliated reproductive medicine practice. PATIENT(S): Ninety-nine patients undergoing their first preimplantation genetic screening (PGS) cycle between January 1 and December 31, 2006. INTERVENTION(S): In vitro fertilization (IVF) and preimplantation genetic screening (PGS). MAIN OUTCOME MEASURE(S): Prevalence of euploidy for chromosomes X, Y, 8, 13, 14, 15, 16, 17, 18, 20, 21, and 22 in day-3 high implantation potential (HIP) versus non-HIP embryos that grew to day-5 blastocysts. RESULT(S): Seven hundred three embryos from 99 cycles in 99 patients underwent PGS. Three hundred sixty-four (52%) embryos from 88 cycles in 88 patients developed to the blastocyst stage by day 5. High implantation potential embryos were more likely to be euploid for chromosomes X/Y, 8, 15, 16, 18, and 22 compared with non-HIP embryos, with similar trends for chromosomes 14 and 17. There were no statistically significant differences between HIP and non-HIP embryos in euploidy prevalence for chromosomes 13, 20, and 21. CONCLUSION(S): Our data suggest that PGS may detect potentially viable but detrimental chromosomal abnormalities that are not detected by embryo morphology alone.
Authors: Denis A Vaughan; Robin Ruthazer; Alan S Penzias; Errol R Norwitz; Denny Sakkas Journal: J Assist Reprod Genet Date: 2015-11-18 Impact factor: 3.412
Authors: Emily C Holden; Laura E Dodge; Rita Sneeringer; Vasiliki A Moragianni; Alan S Penzias; Michele R Hacker Journal: Hum Fertil (Camb) Date: 2017-06-18 Impact factor: 2.767
Authors: Leigh A Humphries; Laura E Dodge; Erin B Kennedy; Kathryn C Humm; Michele R Hacker; Denny Sakkas Journal: J Assist Reprod Genet Date: 2019-06-10 Impact factor: 3.412
Authors: Laura E Dodge; Leslie V Farland; Katharine F B Correia; Stacey A Missmer; Emily A Seidler; Jack Wilkinson; Anna M Modest; Michele R Hacker Journal: Hum Reprod Date: 2020-07-01 Impact factor: 6.918
Authors: K C Humm; L E Dodge; L H Wu; A S Penzias; B A Malizia; D Sakkas; M R Hacker Journal: J Assist Reprod Genet Date: 2015-09-14 Impact factor: 3.412
Authors: Javier García-Ferreyra; Daniel Luna; Lucy Villegas; Rocío Romero; Patricia Zavala; Roly Hilario; Julio Dueñas-Chacón Journal: Clin Med Insights Reprod Health Date: 2015-11-11